Breast cancer is the most common cancer in women in the United States and
accounts for over 46,000 deaths annually. Several reproductive and
environmental factors have been associated with increased risk. More
recent recognition of the importance of genetic factors has led to renewed
interest in familial breast cancer as a model for studying genetic
susceptibility patterns. Recognizing the need to develop scientifically
and clinically innovative approaches to the epidemiology, carcinogenesis,
and prevention of breast cancer, The Fox Chase Cancer Center (FCCC) has
successfully competed for support to develop a formal program in breast
cancer research. This program will provide the intellectual environment to
foster an interdisciplinary approach to basic, clinical, prevention and
control research that will translate to medical applications aimed at
reducing the incidence and mortality due to breast cancer on a local,
regional and national level.
The purpose of this proposal is to establish within the Breast Cancer
Research Program a Familial Breast Cancer Risk Registry, using the
combined resources of the Fox Chase Cancer Center, Cooper Hospital
University Medical Center, and the Coriell Institute for Medical Research.
This registry will serve as a resource to investigate the interaction
between environmental factors and genetic susceptibility. This effort is
particularly relevant in view of the wealth of information beginning to
emerge from the Human Genome Project, and the implications this
information will have for the counseling of women at increased genetic
risk for breast cancer. The specific aims of this proposal are to: l)
consolidate the existing breast cancer research programs at Fox Chase
Cancer Center and Cooper Hospital University Medical Center into a
comprehensive Breast Cancer Risk Registry, which will combine
sociodemographic data, detailed family history, medical and reproductive
history information, and health behavior characteristics in a cohort of
women with familial breast cancer; 2) assemble a cohort of high risk women
with documented epidemiologic, biologic, genetic and sociodemographic
profiles; and 3) provide access to DNA and tissue specimens, collected,
stored and distributed under conditions of the highest quality control at
Coriell Institute for Medical Research, from these women. This resource
will serve to promote scientific exchange and to foster collaborations
that may lead to advances in our understanding of breast cancer biology.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.